FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

Summary

The purpose of this study is to investigate the safety and immunogenicity of the third vaccination with one of three different concentrations of a TBE vaccine in all subjects who completed two vaccinations in one of the three treatment groups of Baxter study 199 (a dose-finding study to investigate the safety and immunogenicity of two vaccinations with FSME IMMUN NEW in healthy subjects aged 1 to 6 years).

Timeline

Start

2002-02

Primary completion

—

Completion

2002-08

Drugs

Indications